[{"id":"7fd7343b-e00a-415f-aa0d-62ed50ea285e","acronym":"","url":"https://clinicaltrials.gov/study/NCT02051257","created_at":"2021-01-18T09:25:59.407Z","updated_at":"2025-02-25T16:43:46.952Z","phase":"Phase 1","brief_title":"Memory Enriched T Cells Following Stem Cell Transplant in Treating Patients With Recurrent B-Cell Non-Hodgkin Lymphoma","source_id_and_acronym":"NCT02051257","lead_sponsor":"City of Hope Medical Center","biomarkers":" CD28","pipe":" | ","alterations":" CD28 expression","tags":["CD28"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD28 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD19 CAR T cells"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 51","initiation":"Initiation: 06/19/2014","start_date":" 06/19/2014","primary_txt":" Primary completion: 03/24/2025","primary_completion_date":" 03/24/2025","study_txt":" Completion: 03/24/2025","study_completion_date":" 03/24/2025","last_update_posted":"2025-02-06"},{"id":"310e9d9a-b69c-4442-97f5-d4d4ad2729a2","acronym":"NCI-2018-00918","url":"https://clinicaltrials.gov/study/NCT03449108","created_at":"2022-07-22T15:57:20.497Z","updated_at":"2024-07-02T16:35:02.803Z","phase":"Phase 2","brief_title":"LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas","source_id_and_acronym":"NCT03449108 - NCI-2018-00918","lead_sponsor":"M.D. Anderson Cancer Center","biomarkers":" HER-2 • CD8 • CD28 • CD27","pipe":" | ","alterations":" CD8 expression • CD28 expression","tags":["HER-2 • CD8 • CD28 • CD27"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD8 expression • CD28 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Opdivo (nivolumab) • Yervoy (ipilimumab) • cyclophosphamide • fludarabine IV • Proleukin (aldesleukin) • LN-145 • LN-145-S1"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 30","initiation":"Initiation: 04/27/2018","start_date":" 04/27/2018","primary_txt":" Primary completion: 06/30/2025","primary_completion_date":" 06/30/2025","study_txt":" Completion: 06/30/2025","study_completion_date":" 06/30/2025","last_update_posted":"2024-05-17"},{"id":"8c229a43-88ef-4aa6-9cca-dad9d1af3b1b","acronym":"","url":"https://clinicaltrials.gov/study/NCT03457142","created_at":"2021-01-18T17:02:40.865Z","updated_at":"2025-02-25T14:38:10.967Z","phase":"Phase 2","brief_title":"Abatacept, Ixazomib Citrate, and Dexamethasone in Treating Patients With Multiple Myeloma Resistant to Chemotherapy","source_id_and_acronym":"NCT03457142","lead_sponsor":"Roswell Park Cancer Institute","biomarkers":" IL6 • CD28 • CD86","pipe":" | ","alterations":" CD28 expression • IL6 expression","tags":["IL6 • CD28 • CD86"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD28 expression • IL6 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Ninlaro (ixazomib) • Orencia (abatacept)"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 15","initiation":"Initiation: 09/11/2018","start_date":" 09/11/2018","primary_txt":" Primary completion: 11/21/2022","primary_completion_date":" 11/21/2022","study_txt":" Completion: 01/11/2025","study_completion_date":" 01/11/2025","last_update_posted":"2024-05-16"},{"id":"52750e71-c473-47c9-a697-eb60cc06c36f","acronym":"","url":"https://clinicaltrials.gov/study/NCT04139070","created_at":"2021-01-18T20:12:43.297Z","updated_at":"2024-07-02T16:36:41.845Z","phase":"Phase 1","brief_title":"Electrochemotherapy for Non-curable Gastric Cancer","source_id_and_acronym":"NCT04139070","lead_sponsor":"Zealand University Hospital","biomarkers":" CD8 • PD-1 • CD28","pipe":" | ","alterations":" CD28 expression","tags":["CD8 • PD-1 • CD28"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD28 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e bleomycin"],"overall_status":"Unknown status","enrollment":" Enrollment 8","initiation":"Initiation: 06/15/2020","start_date":" 06/15/2020","primary_txt":" Primary completion: 01/01/2021","primary_completion_date":" 01/01/2021","study_txt":" Completion: 07/01/2021","study_completion_date":" 07/01/2021","last_update_posted":"2020-08-20"}]